GE HealthCare Technologies (GEHC) revenue increased in Q3 by 7.2% y/y to 5.51 billion USD, and earnings per share (reported) increased by 38.8% y/y to 1.36 USD.

Quarterly results#

Earnings per share (reported, basic) was 1.36 USD (+38.8% y/y), while earnings per share (adjusted) reached 1.34 USD (+25.2% y/y).

Company guidance#

The company expects for the full year 2026 organic revenue growth at 4.0%, EBIT margin in the range of 15.5% – 15.7%, tax rate of 20.0% – 21.0%, earnings per share (adjusted) in the range of 4.95–5.05 USD (an increase of 7.9% – 10.1%), and free cash flow of at least 1.60 billion USD.

Management commentary#

Management emphasized that imaging technologies are at the top of customers’ investment expenditure lists, and sales of the new PET imaging product are progressing as expected. According to management, the sales opportunity pipeline remains strong and growing, which forms the basis of market resilience. Management also indicated that the development of data centers and AI affects the availability of certain components, however, the company has secured priority in deliveries and pricing. According to management, year-end guidance reflects current strength, while maintaining caution regarding the changing macroeconomic environment.